Basic information Safety Supplier Related

tert-Butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylate

Basic information Safety Supplier Related

tert-Butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylate Basic information

Product Name:
tert-Butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylate
Synonyms:
  • tert-butyl 4-(4-Bromo-2-pyridyl)piperazine-1-carboxylate
  • EOS-60591
  • tert-Butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylate
  • 4-(4-Bromopyridin-2-yl)piperazine, N1-BOC protected
  • tert-Butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylate, 1-(4-Bromopyridin-2-yl)-4-(tert-butoxycarbonyl)piperazine
  • 1-Boc-4-(4-bromo-2-pyridyl)piperazine
  • 1-Piperazinecarboxylic acid, 4-(4-bromo-2-pyridinyl)-, 1,1-dimethylethyl ester
  • Palbociclib Impurity 168
CAS:
1197294-80-6
MF:
C14H20BrN3O2
MW:
342.23
Mol File:
1197294-80-6.mol
More
Less

tert-Butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylate Chemical Properties

Boiling point:
442.8±45.0 °C(Predicted)
Density 
1.372±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
8.34±0.10(Predicted)
Appearance
White to off-white Solid
More
Less

Safety Information

HS Code 
29333990
More
Less

tert-Butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylate Usage And Synthesis

Uses

tert-butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylate is a useful reactant for the synthesis of sulfonyl fluorides from aryl bromides with the help of a palladium catalyst.

Synthesis

128071-98-7

57260-71-6

1197294-80-6

General procedure for the synthesis of tert-butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylate from 4-bromo-2-fluoropyridine and N-BOC-piperazine: 1. 4-Bromo-2-fluoropyridine (1.55 g, 8.81 mmol), N-BOC-piperazine (2.46 g, 13.22 mmol) and potassium carbonate (3.65 g, 26.41 mmol) were suspended in dimethyl sulfoxide (10 mL) in a dry reactor. 2. The reaction mixture was transferred to a sealed tube, heated at 100 °C and stirred overnight. 3. Upon completion of the reaction, the mixture was cooled to room temperature and extracted by adding ethyl acetate and water. 4. The organic layer was separated, washed with brine and subsequently dried over anhydrous magnesium sulfate. 5. The solvent was evaporated under pressure to give the crude product. 6. Purification of the crude product by fast column chromatography (elution gradient: 100% hexane to 1:4 hexane/ethyl acetate) afforded the title compound tert-butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylate (2.33 g, 78% yield) as a white solid. LRMS (m/z): 342/344 [M+1]+.

References

[1] Patent: WO2012/41476, 2012, A1. Location in patent: Page/Page column 60
[2] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 17, p. 5419 - 5423
[3] Patent: EP2441755, 2012, A1. Location in patent: Paragraph 0176
[4] Patent: EP2489663, 2012, A1. Location in patent: Paragraph 0095; 0096; 0097

tert-Butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylateSupplier

ForeChem (Nantong) Technology Co.,Ltd.
Tel
513-85982855 18921614129
Email
sales@xianxingpharm.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Email
sales@chemreagents.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
chenyj@titansci.com
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66113011 17798518460
Email
cfzhang@aikonchem.com